Inhibition of the growth of rhabdoid tumors with lack of the SMARCB1, through knockdown of the SWI/SNF catalytic subunit SMARCA4, suggests that the survival of such tumor cells may depend on the residual activity of the SWI/SNF complex. The gene discussed is SMARCA4; the disease is neoplasm.